Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: NAG22, L-CAD, LCAD, H-CAD, HCAD, CDM
Anti-CALD1 Monoclonal Antibody
(5U999)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 20 µL | Inquiry | 7-10 days | 7-10 days | |
| 50 µL | Inquiry | 7-10 days | 7-10 days | |
| 100 µL | Inquiry | 7-10 days | 7-10 days |
| Description | Anti-CALD1 Monoclonal Antibody (5U999) is a Mouse antibody targeting CALD1. Anti-CALD1 Monoclonal Antibody (5U999) can be used in IHC,FCM. |
| Synonyms | NAG22, L-CAD, LCAD, H-CAD, HCAD, CDM |
| Ig Type | IgG1 |
| Clone | 5U999 |
| Reactivity | Human |
| Application | |
| Recommended Dose | IHC: 1/200-1/1000; FCM: 1/200-1/400 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Purified by protein A or protein G |
| Appearance | Liquid |
| Formulation | PBS with 0.05% sodium azide |
| Concentration | 1 mg/ml |
| Research Background | This gene encodes a calmodulin- and actin-binding protein that plays an essential role in the regulation of smooth muscle and nonmuscle contraction. The conserved domain of this protein possesses the binding activities to Ca(2+)-calmodulin, actin, tropomyosin, myosin, and phospholipids. This protein is a potent inhibitor of the actin-tropomyosin activated myosin MgATPase, and serves as a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008] |
| Conjucates | Unconjugated |
| Immunogen | Purified recombinant fragment of human CALD1 (AA: 26-207) expressed in E. Coli. |
| Antigen Species | Human |
| Gene Name | CALD1 |
| Gene ID | |
| Protein Name | Caldesmon |
| Uniprot ID |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.